Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000689079 | SCV000816717 | uncertain significance | Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency | 2022-06-20 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This sequence change replaces methionine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 90 of the CTLA4 protein (p.Met90Val). This variant is present in population databases (rs370443546, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with CTLA4-related conditions. ClinVar contains an entry for this variant (Variation ID: 568653). |